Sambrinvest
Venture Capital
Active
Charleroi, Belgium
31
9M
26
0.82
4
0.13
1
- Areas of investment
Investor highlights
- Industry focus
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 31
- Lead investments
- 4
- Exits
- 1
- Rounds per year
- 0.82
- Follow on index
- 0.13
- Investments by industry
- Biotechnology (11)
- Health Care (10)
- Information Technology (8)
- Medical (5)
- Pharmaceutical (4) Show 40 more
- Investments by region
-
- Belgium (24)
- France (3)
- Spain (1)
- Netherlands (2)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Group Appearance index
- 0.90
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Amyl Therapeutics | 03 Jun 2021 | Biotechnology, Health Care, Medical, Life Science | Early Stage Venture | 10M | Liège, Liege, Belgium |
| EsoBiotec | 30 Sep 2021 | Biotechnology | Seed | 3M | Brabant Wallon, Mont-saint-guibert, Belgium |
| SavvyCard | 24 Oct 2011 | Automotive, Real Estate, Software, Consumer, SaaS, Marketing, Advertising | Seed | 300K | United States, Florida, Saint Petersburg |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.